Frontiers in New Drug Discovery: From Molecular Targets to Preclinical Trials (MDPI - Multidisciplinary Digital Publishing Institute, 2023)
Keywords: A375 melanoma cells; acetylcholinesterase inhibitors; Alzheimer’s disease; anti-cancer; anti-inflammatory substance; antimicrobials; arylazo sulfones; azomethine ylide; Biology, life sciences; biomarker; butyrylcholinesterase inhibitors; cancer prognosis; cancer severity; central nervous system; cycloaddition; cytotoxic activity; cytotoxicity; deep neural network; diffuse large B cell lymphoma (DLBCL); DNA binding; DNA cleavage; DNA photocleavage; drug combination; drug discovery; epithelial regeneration; ex vivo; five-coordinate complexes; glycoconjugation; inflammation; Kunitz-type peptides; LASSBio-1524 analogues; lipophilicity; MAFB; magnetic resonance imaging; Mathematics and Science; MD simulation; metformin; minipigs; molecular docking; N-acylhydrazone; n/a; naphthyl-N-acylhydrazone; natural products; neuroprotective activity; N–S bond homolysis; P2X7R; Parkinson’s disease (PD); phosphacoumarin; photodynamic therapy; platinum(II); pravastatin; prostate cancer; protein X-ray structure; QSAR; quantum chemistry; radiation-induced intestinal injury; radicals; Reference, Information and Interdisciplinary subjects; Research and information: general; sea anemones; Streptococci; TRPV1; tumor-associated macrophages